NEW YORK (Reuters Health) – Dabigatran (Pradaxa, Boehringer Ingelheim) is as effective as warfarin in preventing stroke and systemic embolism after cardioversion in patients with nonvalvular atrial fibrillation,…
Doctors often prescribe unfractionated heparin to obese patients with venous thromboembolism below the recommended doses based on body weight, according to a new study. As a result, some…
NEW YORK (Reuters Health) – Patients with pneumonia and blood oxygen saturation less than 90% are usually hospitalized. Yet, results of new study suggest that the threshold for…
NEW YORK (Reuters Health) – The authors of a systematic review and meta-analysis of relevant studies encourage clinicians to exercise good judgment in using the injectable antibiotic tigecycline…
NEW YORK (Reuters Health) – In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs)…
NEW YORK (Reuters Health) – Anticoagulation with low-molecular-weight heparin (LMWH) dalteparin following heart valve surgery leads to fewer adverse events than does unfractionated heparin, Canadian researchers report in…
NEW YORK (Reuters Health) – Restricting fluids excessively during major abdominal surgery, even using an individualized “goal-directed fluid strategy,” increases the risk of hypovolemia and impairs organ function…
NEW YORK (Reuters Health) – Alpha-blockers and antibiotics relieve symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) better than other therapies, according to a network meta-analysis in the…
Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the…